A Biden Win and Republican Senate Might Lead to Gridlock on Health Issues
If Democrat Joe Biden is successful in his bid for the presidency but the Senate remains in GOP control, Democrats’ plans for major changes in health care may be curbed.
Trump Administration
701-720 of 1,286 results
-
-
California’s Progressive — and Expensive — Health Care Ambitions Rely on Biden Win
There couldn’t be more at stake for California’s Democratic health care agenda in the presidential race. State lawmakers are already penning big-ticket legislation they hope to pursue should Democrat Joe Biden win, from single-payer to a new wealth tax.
By Angela Hart -
‘It’s Science, Stupid’: A School Subject Emerges as a Hot-Button Political Issue
Science is becoming increasingly politicized, so how will it fare on the campaign trail — in 2020 and beyond?
-
A $200 Debit Card Won’t Do Much for Seniors’ Drug Costs
President Donald Trump wants to send seniors $200 apiece. Beyond the legal and logistical problems, health care experts point out it does little to help someone with even typical prescription costs.
By Harris Meyer -
KHN’s ‘What the Health?’: As Cases Spike, White House Declares Pandemic Over
Former President Barack Obama says President Donald Trump is “jealous of COVID’s media coverage.” Indeed, Trump has complained at his rallies, attended by mostly maskless supporters, about how the media covers the pandemic — at a time when cases are rising rapidly across the nation. Meanwhile, open enrollment is about to begin for the Affordable Care Act in a year when many people need coverage, but the law’s future is not secure. Joanne Kenen of Politico, Tami Luhby of CNN and Anna Edney of Bloomberg News join KHN’s Julie Rovner to discuss these issues and more. Plus, Rovner interviews KHN’s Anna Almendrala about the latest KHN-NPR “Bill of the Month” installment.
-
A $10,000 Obamacare Penalty? Doubtful.
Experts said a penalty of $10,000 in one year would have been extremely unlikely.
-
The Trump Medicaid Record: Big Goals, Yet Few Successes
The Trump administration sought to shrink the federal-state health program for low-income Americans and give states more flexibility. But Democrats and the courts thwarted most of those efforts.
-
If Trump Wins, Don’t Hold Your Breath Waiting for That ACA Replacement Plan
The administration seeks to have the Supreme Court overturn the federal health law but has not explained how it would ensure Americans’ health care coverage.
By Julie Rovner -
Florida Fails to Attract Bidders for Canada Drug Importation Program
No private firms bid on the $30 million contract to set up and operate the state’s plan to bring in cheaper drugs. The setback is likely to delay by at least several months Florida’s effort to become the first state to import drugs under new federal regulations.
-
Colorado Initiative Would Further Limit Access in Middle America’s ‘Abortion Desert’
Colorado voters will decide whether to ban most abortions after 22 weeks of pregnancy, which would eliminate a haven for people seeking to end their pregnancies in the Midwest and Mountain West.
-
Arguing to Undo the ACA. Harming Medicare. Do They Go Hand in Hand?
A Biden campaign ad out this month attacks President Donald Trump for pushing to slash Medicare benefits. A campaign spokesperson said the claim comes from the administration’s support for a legal challenge to the Affordable Care Act that seeks to nullify the entire law.
-
In Tamer Debate, Trump and Biden Clash (Again) on President’s Pandemic Response
Trump claims the U.S. is "rounding the corner" on COVID, while Biden predicts a "dark winter." On another front, Trump warns Biden's health care plan will lead to socialized medicine; Biden promises private insurance isn't going anywhere.
-
KHN’s ‘What the Health?’: A Little Good News and Some Bad on COVID-19
Glimmers of hope are beginning to appear in the fight against the coronavirus, such as a decreasing death rate. But there’s not-so-good news, too, including a push for “herd immunity,” which could result in millions more deaths. Meanwhile, the Trump administration doubles down on work requirements for Medicaid. Margot Sanger-Katz of The New York Times, Paige Winfield Cunningham of The Washington Post and Alice Miranda Ollstein of Politico join KHN’s Julie Rovner to discuss these issues and more. Plus, for extra credit, the panelists recommend their favorite health policy stories of the week they think you should read, too.
-
Trump Says He Saved 2 Million Lives From COVID. Really?
The number is taken from a hypothetical modeling scenario that doesn’t offer a realistic comparison.
-
No, the WHO Didn’t Change Its Lockdown Stance or ‘Admit’ Trump Was Right
The World Health Organization has been consistent throughout the pandemic in communicating that lockdowns should be employed only when COVID-19 cases are high — to give governments and health systems time to redouble efforts. Forced closures should not be the primary strategy to combat coronavirus transmission.
-
Pence Said Biden Copied Trump’s Pandemic Response Plan. Pants on Fire!
The vice president went on to point out the underlying philosophical differences between President Donald Trump and Joe Biden regarding their approaches to COVID-19.
-
With Senate Control at Stake, Trump and COVID Haunt Ernst’s Fight to Keep Her Seat
In less than six years, Sen. Joni Ernst has gone from being a rising star in the Republican Party to running neck and neck against a political newcomer. A poll last month showed more than 1 in 3 Iowa voters think Ernst’s relationship to President Donald Trump is “too close,” and her comments about the coronavirus death toll sparked a backlash.
-
As Trump Touts His ‘Great’ COVID Drugs, the Pharma Cash Flows to Biden, Not Him
President Donald Trump has been heralding drugmakers as “great companies.” Yet in the final stretch of the presidential campaign, Trump is not feeling the love in pharma contributions. Former Vice President Joe Biden is, even though his proposed policies could dent the industry’s profitability.
By Jay Hancock -
KHN’s ‘What the Health?’: Trump vs. COVID
President Donald Trump is one of at least two dozen people tied to the White House who have tested positive for COVID-19. Negotiations on the next round of COVID relief are off again — maybe. And the FDA and CDC continue to fight for scientific credibility. Alice Miranda Ollstein of Politico, Kimberly Leonard of Business Insider and Erin Mershon of Stat News join KHN’s Julie Rovner to discuss these issues and more. Plus, Rovner interviews Amy Howe of SCOTUSblog about what the Supreme Court might do with the latest case challenging the constitutionality of the Affordable Care Act.
-
In Debate, Pence and Harris Offer Conflicting Views of Nation’s Reality
During this, the first and only vice presidential debate of the 2020 election season, the two candidates clashed over the coronavirus and other health care issues, as well as a range of other topics.